A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor

[Image: see text] Peptide agonists of the glucagon-like peptide-1 receptor (GLP-1R) have revolutionized diabetes therapy, but their use has been limited because they require injection. Herein, we describe the discovery of the orally bioavailable, small-molecule, GLP-1R agonist PF-06882961 (danuglipr...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffith, David A., Edmonds, David J., Fortin, Jean-Philippe, Kalgutkar, Amit S., Kuzmiski, J. Brent, Loria, Paula M., Saxena, Aditi R., Bagley, Scott W., Buckeridge, Clare, Curto, John M., Derksen, David R., Dias, João M., Griffor, Matthew C., Han, Seungil, Jackson, V. Margaret, Landis, Margaret S., Lettiere, Daniel, Limberakis, Chris, Liu, Yuhang, Mathiowetz, Alan M., Patel, Jayesh C., Piotrowski, David W., Price, David A., Ruggeri, Roger B., Tess, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234956/
https://www.ncbi.nlm.nih.gov/pubmed/35647711
http://dx.doi.org/10.1021/acs.jmedchem.1c01856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234956/
https://www.ncbi.nlm.nih.gov/pubmed/35647711
http://dx.doi.org/10.1021/acs.jmedchem.1c01856

Ejemplares similares